Hyun-ju Park
Gyeonggi-do, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
Thiazole-Linked N-Hydroxypropanamide Derivatives: Selective HDAC6 Inhibitors with Therapeutic Potential for Neurodegenerative Diseases.
Journal: Journal of medicinal chemistry
Published: June 04, 2026
Editor's Note: Deguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited Neurotoxicity.
Journal: Cancer research
Published: May 07, 2026
Synthesis and Translational Assessment of Trinucleotide 5'-Cap Analogs for Messenger Ribonucleic Acid-Based Therapeutics.
Journal: Journal of medicinal chemistry
Published: January 26, 2026
Discovery of Pyrazoloquinazoline Analogues as Orally Bioavailable KRAS-G12D Inhibitors.
Journal: Journal of medicinal chemistry
Published: December 23, 2025
Discovery of novel ENPP1 inhibitors with benzotriazole core for cancer immunotherapy.
Journal: European journal of medicinal chemistry
Published: December 12, 2025
Discovery of Novel Triple A1/A2A/A2B Adenosine Receptor Antagonists for Cancer Immunotherapy.
Journal: Journal of medicinal chemistry
Published: October 22, 2025
Structure-guided design and synthesis of C22- and C32-modified FK520 analogs with enhanced activity against human pathogenic fungi.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 31, 2024
Corrigendum to "Discovery of indazole inhibitors for heat shock protein 90 as anti-cancer agents" [Eur. J. Med. Chem. (2024) 116620].
Journal: European journal of medicinal chemistry
Published: December 25, 2024
Deep Learning-Enhanced Diagnosis of Sow Pregnancy Through Low-Frequency Ultrasound Imaging.
Journal: Animals : an open access journal from MDPI
Published: October 31, 2024
Corrigendum: Cellular heterogeneity and plasticity during NAFLD progression.
Journal: Frontiers in molecular biosciences
Published: October 15, 2024
Structure-guided design and synthesis of C22- and C32-modified FK520 analogs with enhanced activity against human pathogenic fungi.
Journal: bioRxiv : the preprint server for biology
Published: October 10, 2024
Structure-activity relationship studies of Imidazo[1',2':1,6]pyrido[2,3-d]pyrimidine derivatives to develop selective FGFR inhibitors as anticancer agents for FGF19-overexpressed hepatocellular carcinoma.
Journal: European journal of medicinal chemistry
Published: September 27, 2024
Last Updated: 09/26/2026